Spinal cord markers in ALS: Diagnostic and biomarker considerations

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 5, 2012, Pages 407-415

  Bede, Peter ^a   Bokde, Arun L W ^a   Byrne, Susan ^a   Elamin, Marwa ^a   Fagan, Andrew J ^b   Hardiman, Orla ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b St James's Hosiptal   (Ireland)

Author keywords

ALS; Biomarkers; Diffusion tensor imaging; Magnetic Resonance Imaging; Magnetic resonance spectroscopy; Spinal Cord; Transcranial magnetic stimulation

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; BLOOD BRAIN BARRIER; BRAIN ELECTROPHYSIOLOGY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE MUTATION; HUMAN; IMMUNE RESPONSE; MAGNETIC RESONANCE MICROSCOPY; MICROSCOPY; MULTIPLE SCLEROSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PYRAMIDAL TRACT; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SPINAL CORD; SPINAL CORD ATROPHY; SPINAL CORD INJURY; SYSTEMATIC REVIEW; TRANSCRANIAL MAGNETIC STIMULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOLOGICAL MARKERS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; HUMANS; SPINAL CORD; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84865323251     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.649760     Document Type: Review

References (107)

1. Ryberg H, Bowser R. Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev Proteomics. 2008;5:249-62.
2. Grosskreutz J, Peschel T, Unrath A, Dengler R, Ludolph AC, Kassubek J. Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph. Lateral Scler. 2008;9:238-48.
3. Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009; 8:94-109.
4. Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, Benatar M, et al. Towards a neuroimaging biomar-ker for amyotrophic lateral sclerosis. Lancet Neurol. 2011; 10:400-3.
5. Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, et al. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain. 2007;130:2211-9.
6. Facon D, Ozanne A, Fillard P, Lepeintre JF, Tournoux-Facon C, Ducreux D. MR Diffusion Tensor Imaging and Fiber Tracking in Spinal Cord Compression. AJNR Am J Neuroradiol. 2005;26:1587-94.
7. Ellingson BM, Ulmer JL, Kurpad SN, Schmit BD. Diffusion Tensor MR Imaging in Chronic Spinal Cord Injury. AJNR Am J Neuroradiol. 2008;29:1976-82.
8. Sagiuchi T, Iida H, Tachibana S, Kusumi M, Kan S, Fujii K. Case report: diffusion-weighted MRI in anterior spinal artery stroke of the cervical spinal cord. J Comput Assist Tomogr. 2003;27:410-4.
9. Ducreux D, Lepeintre JF, Fillard P, Loureiro C, Tadie M, Lasjaunias P. MR Diffusion Tensor Imaging and Fiber Tracking in 5 Spinal Cord Astrocytomas. AJNR Am J Neu-roradiol. 2006;27:214-6.
10. Agosta F, Rovaris M, Benedetti B, Valsasina P, Filippi M, Comi G. Diffusion tensor MRI of the cervical cord in a patient with syringomyelia and multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004;75:1647-1647.
11. Renoux J, Facon D, Fillard P, Huynh I, Lasjaunias P, Ducreux D. MR Diffusion Tensor Imaging and Fiber Tracking in Infl ammatory Diseases of the Spinal Cord. AJNR Am J Neuroradiol. 2006;27:1947-51.
12. Ozanne A, Krings T, Facon D, Fillard P, Dumas JL, Alvarez H, et al. MR Diffusion Tensor Imaging and Fiber Tracking in Spinal Cord Arteriovenous Malformations: A Preliminary Study. AJNR Am J Neuroradiol. 2007;28:1271-9.
13. Agosta F, Rocca MA, Valsasina P, Sala S, Caputo D, Perini M. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients.J Neurol Neurosurg Psychiatry. 2009;80:53-5.
14. Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon b-1a (Rebif) treatment trial. J Neurol Neuro-surg Psychiatry. 2003;74:1090-4.
15. Wilson JM, Petrik MS, Grant SC, Blackband SJ, Lai J, Shaw CA. Quantitative measurement of neurodegeneration in an ALS-PDC model using MR microscopy. Neuroimage. 2004;23:336-43.
16. Underwood CK, Kurniawan ND, Butler TJ, Cowin GJ, Wallace RH. Non-invasive diffusion tensor imaging detects white matter degeneration in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Neuroimage. 2011; 55:455-61.
17. Choi JK, Küstermann E, Dedeoglu A, Jenkins BG. Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation. Eur J Neurosci. 2009;30:2143-50.
18. Choi JK, Dedeoglu A, Jenkins BG. Longitudinal monitoring of motor neuron circuitry in FALS rats using in vivo phMRI. Neuroreport. 2010;21:157-62.
19. Iwasaki Y, Kinoshita M, Ikeda K, Takamiya K, Shiojima T. MRI in patients with amyotrophic lateral sclerosis: correlation with clinical features. Int J Neurosci. 1991;59: 253-8.
20. Waragai M. MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology. 1997;39:847-51.
21. Karitzky J, Ludolph AC. Imaging and neurochemical markers for diagnosis and disease progression in ALS. J Neurol Sci. 2001;191:35-41.
22. Waragai M, Shinotoh H, Hayashi M, Hattori T. High signal intensity on T1 weighted MRI of the anterolateral column of the spinal cord in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1997;62:88-91.
23. Terao S, Sobue G, Yasuda T, Kachi T, Takahashi M, Mit-suma T. Magnetic resonance imaging of the corticospinal tracts in amyotrophic lateral sclerosis. J Neurol Sci. 1995; 133:66-72.
24. Thorpe JW, Moseley IF, Hawkes CH, MacManus DG, McDonald WI, Miller DH. Brain and spinal cord MRI in motor neuron disease, J Neurol Neurosurg Psychiatry. 1996;61:314-7.
25. Furby J, Hayton T, Anderson V, Altmann D, Brenner R, Chataway J, et al. Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. Mult Scler. 2008;14:1068-75.
26. Lundell H, Barthelemy D, Skimminge A, Dyrby TB, Biering-Sørensen F, Nielsen JB. Independent spinal cord atrophy measures correlate to motor and sensory defi cits in individuals with spinal cord injury. Spinal Cord. 2011; 49:70-5.
27. Freund PA, Dalton C, Wheeler-Kingshott CA, Glensman J, Bradbury D, Thompson AJ, et al. Method for simultaneous voxel-based morphometry of the brain and cervical spinal cord area measurements using 3D-MDEFT. J Magn Reson Imaging. 2010;32:1242-7.
28. Sperfeld AD, Bretschneider V, Flaith L, Unrath A, Hanemann CO, Ludolph AC, et al. MR-Pathologic Comparison of the Upper Spinal Cord in Different Motor Neuron Diseases. Eur Neurol. 2005;53:74-7.
29. Valsasina P, Agosta F, Benedetti B, Caputo D, Perini M, Salvi F, et al. Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78:480-4.
30. Agosta F, Rocca MA, Valsasina P, Sala S, Caputo D, Perini M, et al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2009;80:53-5.
31. Nair G, Carew JD, Usher S, Lu D, Hu XP, Benatar M. Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis. Neuroimage. 2010;53:576-83.
32. Cohen-Adad J, Descoteaux M, Rossignol S, Hoge RD, Deriche R, Benali H. Detection of multiple pathways in the spinal cord using Q-ball imaging. Neuroimage. 2008;42:739-49.
33. Dowell NG, Jenkins TM, Ciccarelli O, Miller DH, Wheeler-Kingshott CA. Contiguous-slice zonally oblique multislice (CO-ZOOM) diffusion tensor imaging: examples of in vivo spinal cord and optic nerve applications. J Magn Reson Imaging. 2009;29:454-60.
34. Cohen-Adad J, El Mendili MM, Lehéricy S, Pradat PF, Blan-cho S, Rossignol S, et al. Demyelination and degeneration in the injured human spinal cord detected with diffusion and magnetization transfer MRI. Neuroimage. 2011;55:1024-33.
35. Unrath A, Ludolph AC, Kassubek J. Brain metabolites in defi nite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol. 2007;254: 1099-106.
36. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport. 1998;9:1757-61.
37. Kalra S, Genge A, Arnold DL. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:22-6.
38. Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:141-9.
39. Cwik VA, Hanstock CC, Allen PS, Martin WR. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology. 1998;50:72-7.
40. Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology. 1999;53:71-9.
41. Abe K, Takanashi M, Watanabe Y, Tanaka H, Fujita N, Hirabuki N, et al. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology. 2001;43:537-41.
42. Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol. 2001;58:729-35.
43. Henning A, Schär M, Kollias SS, Boesiger P, Dydak U. Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magn Reson Med. 2008;59:1250-8.
44. Carew JD, Nair G, Pineda-Alonso N, Usher S, Hu X, Benatar M. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:185-91.
45. Carew JD, Nair G, Andersen PM, Wuu J, Gronka S, Hu X, et al. Presymptomatic spinal cord neurometabolic fi ndings in SOD1-positive people at risk for familial ALS. Neurology. 2011;77:1370-5.
46. Stanton BR, Williams VC, Leigh PN, Williams SC, Blain CR, Jarosz JM, et al. Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways. J Neurol. 2007;254:1260-7.
47. Palmieri A, Naccarato M, Abrahams S, Bonato M, D'Ascenzo C, Balestreri S, et al. Right hemisphere dysfunction and emotional processing in ALS: an fMRI study. J Neurol. 2010;257:1970-8.
48. Abrahams S, Goldstein LH, Simmons A, Brammer M, Williams SC, Giampietro V, et al. Word retrieval in amyo-trophic lateral sclerosis: a functional magnetic resonance imaging study. Brain. 2004;127:1507-17.
49. Mohammadi B, Kollewe K, Samii A, Krampfl K, Dengler R, Münte TF. Changes of resting state brain networks in amyo-trophic lateral sclerosis. Exp Neurol. 2009;217:147-53.
50. Malisza KL, Stroman P W. Functional imaging of the rat cervical spinal cord. J Magn Reson Imaging. 2002; 16:553-8.
51. Stroman PW, Krause V, Malisza KL, Frankenstein UN, Tomanek B. Functional magnetic resonance imaging of the human cervical spinal cord with stimulation of different sensory dermatomes. Magn Reson Imaging. 2002; 20:1-6.
52. Stroman PW, Kornelsen J, Lawrence J. An improved method for spinal functional MRI with large volume coverage of the spinal cord. J Magn Reson Imaging. 2005;21:520-6.
53. Brooks JC, Beckmann CF, Miller KL, Wise RG, Porro CA, Tracey I, et al. Physiological noise modelling for spinal functional magnetic resonance imaging studies. Neuroimage. 2008;39:680-92.
54. Figley CR, Stroman PW. Development and validation of retrospective spinal cord motion time-course estimates (RESPITE) for spin-echo spinal fMRI: improved sensitivity and specifi city by means of a motion-compensating general linear model analysis. Neuroimage. 2009;44:421-7.
55. Piché M, Cohen-Adad J, Nejad MK, Perlbarg V, Xie G, Beaudoin G, et al. Characterization of cardiac-related noise in fMRI of the cervical spinal cord. Magn Reson Imaging. 2009;27:300-10.
56. Bouwman CJ, Wilmink JT, Mess WH, Backes WH. Spinal cord functional MRI at 3 T: gradient echo echo-planar imaging versus turbo spin echo. Neuroimage. 2008;43:288-96.
57. Stroman PW, Tomanek B, Krause V, Frankenstein UN, Malisza KL. Mapping of neuronal function in the healthy and injured human spinal cord with spinal fMRI. Neuroimage. 2002;17:1854-60.
58. Madi S, Flanders AE, Vinitski S, Herbison GJ, Nissanov J. Functional MR imaging of the human cervical spinal cord. AJNR Am J Neuroradiol. 2001;22:1768-74.
59. Bouwman CJ, Wilmink JT, Mess WH, Backes WH. Spinal cord functional MRI at 3 T: gradient echo echo-planar imaging versus turbo spin echo. Neuroimage. 2008;43:288-96.
60. Kornelsen J, Stroman PW. fMRI of the lumbar spinal cord during a lower limb motor task. Magn Reson Med. 2004; 52:411-4.
61. Agosta F, Valsasina P, Caputo D, Stroman PW, Filippi M. Tactile-associated recruitment of the cervical cord is altered in patients with multiple sclerosis. Neuroimage. 2008;39: 1542-8.
62. Stroman PW, Kornelsen J, Bergman A, Krause V, Ethans K, Malisza KL, et al. Non-invasive assessment of the injured human spinal cord by means of functional magnetic resonance imaging. Spinal Cord. 2004;42:59-66.
63. Komisaruk BR, Mosier KM, Liu WC, Criminale C, Zaborszky L, Whipple B, et al. Functional localization of brainstem and cervical spinal cord nuclei in humans with fMRI. AJNR Am J Neuroradiol. 2002;23:609-17.
64. Filippi M, Agosta F, Abrahams S, Fazekas F, Grosskreutz J, Kalra S, et al. European Federation of Neurological Societies. EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol. 2010;17:526-e20.
65. Chen CJ, Hsu HL, Tseng YC, Lyu RK, Chen CM, Huang YC, et al. Hirayama fl exion myelopathy: neutral-position MR imaging fi ndings. Importance of loss of attachment. Radiology. 2004;231:39-44.
66. Schmalbach S, Petri S, Götz F, Dengler R, Krampfl K. Anterior cysts of the spine: a diffi cult differential diagnosis to amyotrophic lateral sclerosis. J Neurol. 2008;255: 1662-9.
67. Driver-Dunckley ED, Hoxworth JM, Patel NP, Bosch EP, Goodman BP. Superfi cial siderosis mimicking amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2010;11: 137-44.
68. Cercignani M, Horsfi eld MA, Agosta F, Filippi M. Sensitivity-encoded diffusion tensor MR imaging of the cervical cord. AJNR Am J Neuroradiol. 2003;24:1254-6.
69. Holder CA, Muthupillai R, Mukundan S Jr, Eastwood JD, Hudgins PA. Diffusion weighted MR imaging of the normal human spinal cord in vivo. AJNR Am J Neuroradiol. 2000;21:1799-806.
70. Tsuchiya K, Fujikawa A, Suzuki Y. Diffusion Tractography of the Cervical Spinal Cord by Using Parallel Imaging. AJNR Am J Neuroradiol. 2005;26:398-400.
71. Dadon-Nachum M, Melamed E, Offen D. The 'dying-back' phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43:470-7.
72. Davison C. Amyotrophic lateral sclerosis, origin and extent of upper motor neuron lesion. Arch Neurol Psychiatry. 1941;46:1039-56.
73. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J Neurol Neuro-surg Psychiatry. 1970;33:338-57.
74. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232-40.
75. Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805-11.
76. Henkel JS, Beers DR, Zhao W, Appel SH. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol. 2009;4:389-98.
77. Philips T, Robberecht W. Neuroinfl ammation in amyo-trophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253-63.
78. Dibaj P, Steffens H, Zschüntzsch J, Nadrigny F, Schomburg ED, Kirchhoff F, et al. In vivo imaging reveals distinct infl ammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS. PLoS One. 2011; 6:e17910.
79. Henkel JS, Engelhardt JI, Siklós L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221-35.
80. Graber DJ, Hickey WF, Harris B T. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J Neuroinfl ammation. 2010;7:8.
81. Bataveljić D, Djogo N, Zupunski L, Bajić A, Nicaise C, Pochet R, et al. Live monitoring of brain damage in the rat model of amyotrophic lateral sclerosis. Gen Physiol Biophys. 2009;28:212-8.
82. Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, et al. Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res. 2011;1398:113-25.
83. Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol. 2011;70:194-206.
84. Andjus PR, Bataveljić D, Vanhoutte G, Mitrecic D, Pizzolante F, Djogo N, et al. In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach. Anat Rec. 2009;292:1882-92.
85. Miyazaki K, Ohta Y, Nagai M, Morimoto N, Kurata T, Takehisa Y, et al. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res. 2011;89:718-28.
86. Nicaise C, Mitrecic D, Demetter P, de Decker R, Authelet M, Boom A, et al. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009;1301:152-62.
87. Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modelling ALS. Brain Res. 2007;1157:126-37.
88. Verstraete E, Biessels GJ, van den Heuvel MP, Visser F, Luijten PR, van den Berg LH. No evidence of microbleeds in ALS patients at 7 Tesla MRI. Amyotroph Lateral Scler. 2010;11:555-7.
89. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of the human motor cortex. Lancet. 1985; 1:1106-7.
90. Eisen A, Weber M. Neurophysiological evaluation of cortical function in the early diagnosis of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl1):S47-51.
91. Ziemann U, Eisen A. TMS for ALS: why and why not. Clin Neurophysiol. 2004;115:1237-8.
92. Rossini PM, Rossi S. Transcranial magnetic stimulation: diagnostic, therapeutic and research potential. Neurology. 2007;68:484-8.
93. Pouget J, Trefouret S, Attarian S. Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl 2):S45-9.
94. Komissarow L, Rollnik JD, Bogdanova D, Krampfl K, Khabirov FA, Kossev A, et al. Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol. 2004;115:356-60.
95. Rosler KM, Magistris MR. Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol. 2004;115:1715.
96. Argyriou AA, Polychronopoulos P, Talelli P, Chroni E. F-wave study in amyotrophic lateral sclerosis: assessment of balance between upper and lower motor neuron involvement. Clin Neurophysiol. 2006;117:1260-5.
97. Drory VE, Kovach I, Groozman GB. Electrophysiological evaluation of the upper motor neuron involvement in amyo-trophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:147-52.
98. Claus D, Brunholzl C, Kerling FP, Henschel S. Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis. J Neurol Sci. 1995;129 (Suppl):30-4.
99. Trompetto C, Caponnetto C, Buccolieri A, Marchese R, Abbruzzese G. Responses of masseter muscles to transcra-nial magnetic stimulation in patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol. 1998;109:309-14.
100. Mills KR, Nithi KA. Peripheral and central motor conduction in amyotrophic lateral sclerosis. J Neurol Sci. 1998;159:82-7.
101. Triggs WJ, Menkes D, Onorato J, Yan RS, Young MS, Newell K, et al. Transcranial magnetic stimulation identifi es upper motor neuron involvement in motor neuron disease. Neurology. 1999;53:605-11.
102. Schulte-Mattler WJ, Müller T, Zierz S. Transcranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci. 1999;170:51-6.
103. Pouget J, Trefouret S, Attarian S. Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS. Amyotroph Lateral Scler. 2000;1(Suppl 2):S45-9.
104. Urban PP, Wicht S, Hopf HC. Sensitivity of transcranial magnetic stimulation of cortico-bulbar vs. cortico-spinal tract involvement in amyotrophic lateral sclerosis (ALS). J Neurol. 2001;248:850-5.
105. Desiato MT, Bernardi G, Hagi HA, Boffa L, Caramia MD. Transcranial magnetic stimulation of motor pathways directed to muscles supplied by cranial nerves in amyotrophic lateral sclerosis. Clin Neurophysiol. 2002;113:132-40.
106. Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, del Bene ML, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology. 2004;62:1753-7.
107. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257-68.